
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
Leone, Francesco, Marino, Donatella, Cereda, Stefano, Filippi, Roberto, Belli, Carmen, Spadi, Rosella, Nasti, Guglielmo, Montano, Massimo, Amatu, Alessio, Aprile, Giuseppe, Cagnazzo, Celeste, Fasola,Volume:
122
Langue:
english
Journal:
Cancer
DOI:
10.1002/cncr.29778
Date:
February, 2016
Fichier:
PDF, 301 KB
english, 2016